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Optical coherence tomography (OCT) is a non-invasive
imaging modality useful for identification of lesions in the
macula, optic disk and the anterior segment.1 It provides a
high resolution, in vivo optical biopsy of the tissue being
scanned, using the principle of optical interferometry.2,3
OCT can be in the form of Time Domain OCT (TD OCT) or
Fourier domain OCT. In TD OCT a mechanically moving scan-
ning reference arm sequentially measures the echo time
delay.1 Fourier domain OCT has a stationary reference arm
which obtains an interference spectrum which then under-
goes Fourier transformation allowing simultaneous measure-
ments of all echo time delays thereby reducing the image
acquisition time. Fourier domain OCT is again subdivided
into Spectral Domain OCT (SD OCT) which uses a spectrom-
eter and a line scan camera for image acquisition as opposed
to a swept source OCT which has a rapidly tunable laser
source for the same purpose.4Information gathered from OCT can be qualitative or
quantitative in nature. Qualitative data can be in the form
of identification of retinal pathologies like vitreo macular
traction, macular holes, cystoid macular edema and choroidal
neovascular membrane.1 Quantitative data such as foveal
thickness are used to make treatment decisions like in condi-
tions such as age related macular degeneration, diabetic
macular edema and retinal vein occlusions.5–8 Likewise
retreatment decisions are also based to some extent on the
foveal thicknesses obtained by an OCT scan.
Interpretation of these data and their implications in clini-
cal situations must be tempered by the fact that images thus
obtained are subject to artifacts.3 These artifacts can mislead
physicians to wrong diagnosis or inappropriate management.
The first step for an examiner to address the issue of artifacts
is to be aware of the presence of artifacts.9 Knowledge about
the possible artifacts in an OCT image will aid in better inter-
pretation of the disease condition. Here we describe various
types of artifacts and their clinical significance.e:
al.com
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82 J. Chhablani et al.Ray et al. were the first group to report and classify arti-
facts in TD OCT.3 They had identified six types of OCT arti-
facts namely1: misidentification of the inner retinal layer,2
misidentification of the outer retinal layer,3 out of register
artifact,4 degraded image scan,5 cut edge artifact and6 off
center artifact. These artifacts while originally reported in
TD OCT can also be noted in SD OCT. There are certain
other artifacts like mirror artifacts, which are noted exclu-
sively in SD OCT on account of the technique involved in
acquiring the image.4 The artifacts can be a result of software
errors (misidentification of retinal layers, mirror artifact, cut
edge artifact), operator related error (degraded image scan,
out of register artifact, off center artifact) or patient related
factors (motion artifact, off center artifact, degraded image
scan, mirror artifact) (Fig. 1). It is apparent from the above
classification that the causes of some artifacts are not mutu-
ally exclusive.Misidentification of inner retinal layer
All devices used the internal limiting membrane for the
placement of the inner retinal layer. Misidentification of inter-
nal limiting membrane occurs due to software breakdown,
mostly in eyes with epiretinal membrane (ERM), vitreomacu-
lar traction (VMT) or macular hole. Ray et al. found that on
univariate analysis, inner layer misidentification was more
common in eyes with neovascular age related macular
degeneration (AMD), macular holes and eyes which have
undergone photodynamic therapy (PDT).3 However, on mul-
tivariate analysis, they found that the neovascular AMD was
the only condition associated with inner layer misidentifi-
cation. The authors also found inner layer misidentification
in eyes with vitreo-retinal traction but the number was too
small to analyze statistically.
Comparison over different OCT machines (STRATUS (Carl
Zeiss Meditec, Dublin, CA), CIRRUS (Carl Zeiss Meditec, Dub-
lin, CA), RTVue (Optovue, Inc., Fremont, CA), TOPCON (Top-
con Medical Systems, Paramus, NJ)) showed that inner layerFigure 1. Common artifacts on Spectral Domain Optical Coherence Tomograp
incorrect automated segmentation; outer and inner boundaries are misidentif
the incorrect automated segmentation for inner boundary; outer boundary is c
Image appears to be folded onto itself in a high myopic eye; called as mirror a
is not available from the OCT scan as it is shifted inferiorly; called as out of regis
retinal data in between due to blink during scan acquisition, which appears amisidentification was a common feature with all machines
showing artifact in more than 50% of cases.1 Inner layer mis-
identification was most commonly noted in eyes with epireti-
nal membrane (ERM) followed by diabetic macular edema
(DME) and macular hole in STRATUS OCT (Carl Zeiss Medi-
tec, Dublin, CA). Vitreomacular traction (VMT) followed by
ERM and cystoid macular edema (CME) were the most com-
mon conditions with CIRRUS machine (Carl Zeiss Meditec,
Dublin, CA). VMT, ERM and macular hole were the most com-
mon conditions associated with inner layer misidentification
with TOPCON (Topcon Medical Systems, Paramus, NJ) and
RTVue (Optovue, Inc., Fremont, CA) SD OCT machines.1 In-
ner layer misidentification involving the central 1 mm sub
field was noted in 6.7% of CIRRUS (Carl Zeiss Meditec, Dub-
lin, CA) SD OCT machine line scans and 1.3% of SPECTRALIS
SD OCT machine (Heidelberg Engineering, Vista, CA).10
AMD and uveitis were the two conditions where the central
sub field inner layer misidentification was more common
with the CIRRUS SD OCT machine (Carl Zeiss Meditec,
Dublin, CA).
In a study comparing the various OCT machines (STRATUS
(Carl Zeiss Meditec, Dublin, CA), CIRRUS (Carl Zeiss Meditec,
Dublin, CA), TOPCON (Topcon Medical Systems, Paramus,
NJ), RTVue (Optovue, Inc., Fremont, CA), SPECTRALIS (Hei-
delberg Engineering, Vista, CA) and COPERNICUS (Optopol
Tech. SA, Zawiercie, Poland)), the maximum number of errors
in the inner layer misidentification was noted in the COPER-
NICUS (Optopol Tech. SA, Zawiercie, Poland) SD OCT ma-
chine suggesting that an error in software may have a
greater contribution in the artifact rather than the nature of
the machine i.e. TD OCT or SD OCT.11Misidentification of outer retinal layers
Different instruments use different reference points for
outer retinal layers. The STRATUS uses the inner segment–
outer segment junction (IS–OS junction) while the CIRRUS
(Carl Zeiss Meditec, Dublin, CA) and RTVue (Optovue, Inc.,hy. (A) Misidentification of inner and outer retinal layers: Image shows the
ied leading to an artifact. (B) Misidentification of inner layer: image shows
orrectly identified along the retinal pigment epithelium. (C) Mirror artifact:
rtifact. (D) Out of register artifact: Information from the outer retinal layers
ter artifact. (E) Blink artifact: OCT B scan appears discontinued with loss of
s dark line on rendered en-face image (F).
Artifacts in optical coherence tomography 83Fremont, CA) use the retinal pigment epithelium (RPE) as the
outer retinal layer and the TOPCON 3D-OCT 1000 (Topcon
Medical Systems, Paramus, NJ) uses the tip of the outer seg-
ment photoreceptor.1 This artifact commonly occurs in outer
retinal diseases such as central serous retinopathy (CSR),
AMD, CME and geographic atrophy. Eyes with neovascular
AMD and those which had undergone PDT had a greater
chance of outer layer misidentification in a study by Ray et al.3
Interestingly, eyes with posterior vitreous detachment (PVD)
had a greater chance of outer layer misidentification in the
same study.3 CSR followed by CME and neovascular AMD
seemed to be the most common condition associated with
outer layer misidentification.1 In a related study, AMD fol-
lowed by uveitis and diabetic retinopathy seemed to be the
most common cause of outer layer misidentification.10 The
COPERNICUS (Optopol Tech. SA, Zawiercie, Poland) and
RTVue (Optovue, Inc., Fremont, CA) SD OCT machines had
the highest error frequencies in identification of the outer ret-
inal layers in subjects with neovascular AMD.11Implications of misidentification of inner and outer
retinal layers
Inner layer misidentification usually happens in eyes with
vitreo–macular interface disorders for which the manage-
ment involves mainly surgery. Quantitative assessment may
not be essential for management of such disorders. There-
fore, inner retinal misidentification is less important than out-
er retinal misidentification. Outer retinal misidentification
occurs mostly in neovascular AMD, CSR, and CME, in which
quantitative assessment becomes important for manage-
ment of such cases. Leung et al. and Forooghian et al. found
significantly different macular thickness measurements be-
tween time domain and spectral domain systems, with both
groups finding higher thickness measurements in SD OCT
as compared to TD OCT.12,13 Similar finding was also noted
by Mylonas et al.14 Improper delineation of retinal layers re-
sult in improper assessment of foveal thickness. As stated
previously, quantitative data (foveal thickness) help in treat-
ment as well as follow up decisions. Sadda et al. found error
in thickness measurement in 92% of all scans.2 However, the
quantum of severe errors, which was arrived at using a grad-
ing system stood at 13%. In eyes with neo-vascular AMD
undergoing treatment with anti VEGF therapy, an error of
74% has been reported when measuring foveal thickness.15
This error was reduced to 60% on repeat scan suggesting
that repeat scans reduce but do not completely eliminate
the error. This is a matter of concern as retreatment decisions
are made based on foveal thickness.5
It has been suggested that when such artifacts are identi-
fied a manual measurement of the thickness can help us cir-
cumvent the problem.9,15 Ho et al. had suggested that a
difference of 11 microns between the software generated
thickness and manual measurement need to be considered
clinically significant.1 The difference between the two mea-
surements was the greatest for STRATUS TD OCT machine
while it was the least for CIRRUS SD OCT machine (Carl Zeiss
Meditec, Dublin, CA). They also reported a poor range of
agreement for TD OCT (from 309 lm to 396 lm), and con-
cluded that thickness measurements obtained from time do-
main systems could not be directly compared to SD OCT.Ho et al.1 found that STRATUS OCT (TD OCT) created sig-
nificantly higher rates of clinically significant errors compared
to any of the Fourier domain OCT. However, TD OCT did not
perform the poorest out of the entire artifact types analyzed.
In fact to their surprise, STRATUS OCT scans had the lowest
percentage of outer retina misidentification.
They suggested that while SD OCT technology may be
superior in terms of decreasing the overall number of clini-
cally significant segmentation errors, differences in technol-
ogy may not be the only factor in the determination of
segmentation breakdown rates. They stated that other fac-
tors such as the quality of the segmentation software written
for the OCT device may, in fact, play a very important role in
determining the incidences of segmentation errors present
for a device.
Mirror artifact/inverted artifact
These are noted only in Fourier domain OCT machines,
which reconstruct the image around the region of zero time
delay. The machine is unable to distinguish between negative
and positive time delays and hence produce images around
the zero time delay line, which are usually mirror images.
The sensitivity also gets reduced as the image is formed away
from the zero time delay line causing development of greater
amount of interference.4 Subjects with higher myopic spher-
ical equivalent, less visual acuity and a longer axial length had
a greater chance of mirror artifacts. This can also occur in
eyes with raised lesion such as choroidal tumor, retinal
detachment or retinoschisis. The mirror artifacts were noted
in 9.3% of all scans and were noted in the periphery of the
scan in view of the greater curvature of the globe leading
to the peripheral area of the scanned retina traversing the
zero time delay zone.4 Han et al. found inverted artifacts
more commonly in CIRRUS SD-OCT (Carl Zeiss Meditec,
Dublin, CA) as compared to SPECTRALIS (Heidelberg Engi-
neering, Vista, CA).10 As the mirror artifact is usually due to
an increase in the height of lesion (macular traction) or in-
creased depth of lesion, it would be ideal to have an addi-
tional scan keeping the non-macular area of interest in the
center of the scan to gather further information from the
pathology thereby reducing the chance of a mirror artifact
Out of register artifact
Out of register artifact is defined as a condition where the
scan is shifted superiorly or inferiorly such that some of the
retinal layers are not fully imaged.3 The prevalence of this
artifact ranges from 2.4% to 13% across different TD OCT
and SD OCT machines.1,3 This is generally an artifact, which
is operator dependent and caused due to misalignment of
the scan.1,9 It can be rectified by bringing the scan to the cen-
ter of the frame.
Degraded image
Degraded images are due to poor image acquisition and
have been noted in 11% of cases in a study by Ray et al.3
These images were generally associated with non-retinal
diagnosis. In the presence of a degraded image, the software
is unable to delineate the inner and outer retinal layers prop-
erly resulting in errors of foveal thickness measurement. As
84 J. Chhablani et al.the OCT uses a near infrared beam to acquire images, the
presence of media opacity like cataract may not be a cause
for a degraded image.9 This artifact is probably due to poor
image acquisition and can be rectified by refocusing on the
area of interest.Cut edge artifact
This is an artifact where the edge of the scan is truncated.3
Cut edge artifacts were noted in 2.3–6.35% of scans.3,16
These artifacts result in abnormality in peripheral part of
the scan and do not affect the central retinal thickness mea-
surements. Cut edge artifacts are seen with similar frequency
in normal and diseased eyes. These are operator induced
artifacts due to poor scan acquisition and often occur during
the first scan and can be overcome by disregarding the first
scan.9Off center artifact
This happens due to a fixation error, causing the displace-
ment of the central foveal subfield of the early treatment dia-
betic retinopathy study (ETDRS)-like map by more than
0.25 mm from the true center based on topographic map
and OCT B-scan data.16 This happens mostly with subjects
with poor vision, eccentric fixation or poor attention. This
abnormal representation of the fovea was translated into
inaccurate foveal thickness measurement. Similar error can
happen with retinal nerve fiber layer measurement as well
(Fig. 2). An error of 44.5% in foveal thickness was noted in
eyes with a decentration of 0.5 mm and the quantum of devi-
ation only increases with further decentration.17 Univariate
analysis showed an association of neovascular AMD with off
center artifact.3 This artifact can be rectified manually by
the OCT operator by looking at the rendered fundus image
of the OCT or repeating the scan using external fixation.10
SPECTRALIS (Heidelberg Engineering, Vista, CA), RTVue100
(Optovue, Inc., Fremont, CA) and TOPCON 3D-OCT (Topcon
Medical Systems, Paramus, NJ) have the facility to manually
reposition the foveal center in slightly off center scans.Motion artifact
These artifacts are noted due to ocular saccades, change
of head position or due to respiratory movements.18,19 They
can occur due to poor tracking system, even with heart beat
or respiration. They can be detected by noting the misalign-
ment of the retinal blood vessels in the rendered fundus im-
age. It has been reported as a double fovea artifact possibly
due to a micro saccade.20 Motion artifacts are common in
TD-OCT but are difficult to detect as the rendered fundus im-
age is taken after the OCT scan. Though the SD OCT scan
acquisition time is lesser, they are not totally immune from
motion artifacts. Motion artifacts are known to result in seg-
mentation error especially abnormal retinal nerve fiber layer
thickness measurement. Therefore artifacts showing more
than one vessel shift need to be discarded and the scan is re-
peated. This artifact can be overcome by eye tracking system
such as Heidelberg, however, eye tracking reduces only
transverse motion, but not axial motion. Sometimes, repeat-
ing the scan may be required. Several techniques have beenproposed to reduce the motion artifacts on SD-OCT and
swept source OCT.21,22
Blink artifacts
These are noted when the patient blinks during the pro-
cess of scan which are noted as areas of blanks in the ren-
dered en-face image and macular thinning on macular map.
B scan shows lost retinal data in between. The operator
needs to repeat the image if such an artifact is noted.9
What is a clinically significant artifact?
 Any artifact resulting in automated segmentation errors of
more than 10% of the actual (manually measured) ETDRS
center subfield thickness (CST) is considered as clinically
significant.23,24
 Any artifact resulting in an error is more than 50 lm. This is
based on a study of reproducibility in STRATUS TD OCT
that suggests 50 lm as a cutoff for retreatment of neovas-
cular AMD patients.15
 Artifacts resulting in misdiagnosis of retinal thickening or
thinning are noted as significant. Cutoffs are generated
using published normative data for CIRRUS (Carl Zeiss
Meditec, Dublin, CA) and SPECTRALIS (Heidelberg Engi-
neering, Vista, CA) and by defining retinal thickening or
thinning as the mean ± 2 standard deviations.25
Clinical significance of artifacts
OCT is useful in tracking disease progression and treat-
ment response as well as to provide outcome measures for
treatment success or failure in a variety of retinal pathologic
features, including diabetic macular edema, uveitic cystoid
macular edema, and neovascular AMD.26,27
In clinical trials, OCT plays a major role for quantitative
measurement of retinal thickness. OCT retinal thickness mea-
surements are important in defining inclusion and exclusion
criteria in clinical studies (e.g., foveal thickness of more than
250 or 300 lm for studies of macular edema). OCT retinal
thickness measurements are important in guiding treatment
and re-treatment during clinical trials (e.g., retreat if there
is more than 100 lm increase in retinal thickness in neovascu-
lar AMD).26–29
Presence of artifacts on OCT would affect the quantitative
as well as qualitative assessment of retinal diseases during
treatment planning and response in clinics as well as in clini-
cal trials.
Evaluation of artifacts among various oct machines
To evaluate artifact errors, Giani et al.11 obtained error fre-
quency (EF-exam), which was calculated as the percentage of
OCT examinations that included at least one B-scan with an
artifactual error. To account for the different number of scan
lines and variable B-scan density of each instrument, the
absolute number of errors produced by each instrument
was recorded, and the ratio of total number of errors per to-
tal number of B-scans for each machine was calculated (EF-
scan).
They noted that the total EF-exam of all OCT instruments
was 25.8%. In healthy subjects, the EF-exam for all instru-
Figure 2. Off center centration. (A) Retinal nerve fiber layer (RNFL) scan with proper centration over the optic nerve head (upper right corner) showing
normal RNFL thickness. (B) RNFL scan of the same eye with off center centration over the optic nerve head (upper right corner) showing (artificial)
abnormalities of RNFL thickness.
Artifacts in optical coherence tomography 85ments was 6.9%, whereas in pathologic eyes, the EF-exam
was 32.7%. The highest was for macular holes, 83.3%, fol-
lowed by epiretinal membrane with cystoid macular edema,
66.6%, and neo-vascular AMD, 50.3%. The CIRRUS (Carl
Zeiss Meditec, Dublin, CA) and 3D OCT-1000 (Topcon Med-
ical Systems, Paramus, NJ) instruments had the lowest EF-
exam values with 8.2% and 16.6%, respectively, whereas
the other devices had higher EF-exam values, varying from
24.7% for the SPECTRALIS (Heidelberg Engineering, Vista,
CA) to 49.5% for the COPERNICUS (Optopol Tech. SA, Zaw-
iercie, Poland). The STRATUS (Carl Zeiss Meditec, Dublin,
CA), the only TD-OCT in their study, had an EF-exam of26.61%. The COPERNICUS (Optopol Tech. SA, Zawiercie,
Poland) compiled the highest number of total errors com-
pared with the other instruments and the authors attributed
this result due to a more complex analysis for retinal segmen-
tation used by this OCT machine as compared to others.
When the number of B-scans per study was taken into ac-
count, the STRATUS (Carl Zeiss Meditec, Dublin, CA) was the
instrument with the highest EF-scan, even compared with the
COPERNICUS (Optopol Tech. SA, Zawiercie, Poland). This
observation was explained by the study group due to utiliza-
tion of the radial line protocol (which included six scans) by
the STRATUS (Carl Zeiss Meditec, Dublin, CA) machine and
Table 1. OCT artifact and what to do?
OCT artifact Remedial measure
Inner layer
misidentification
Manual correction
Outer layer Manual correction
86 J. Chhablani et al.thus the EF-exam could not accurately describe the clinical
significance in comparison to EF-scan. They thus concluded
that EF-scan determination may be more important when
comparing the ability of different instruments to accurately
create a retinal thickness map.misidentification
Mirror artifact Retake the scan in the area of interest
Degraded image Repeat scan after proper positioning
Out of register scan Repeat the scan after realigning the area
of interest
Cut edge artifact Ignore the first scan
Off center artifact Retake the scan/manually plot the fovea
Motion artifact Retake the scan
Blink artifact Retake the scanArtifacts based on pathology
Studies by various authors2,3,12,30 have shown that the
severity of retinal abnormalities is directly connected to the
frequency of imaging errors. Giani et al.11 proposed that this
could occur because the software tries to identify the normal
pattern of hyper- and hypo-reflective layers on each single A-
scan. Pathologic conditions lead to haphazard remodeling of
the retinal segmentation that is strictly dependent on the
severity and the type of alteration. They observed, however,
that the errors produced by different instruments were often
similar in certain pathologic conditions. They inferred that it
was likely because for all the devices, different layers were
recognized using algorithms that identified gray value varia-
tions along the A-scan lines.
The authors concluded that CIRRUS (Carl Zeiss Meditec,
Dublin, CA), SPECTRALIS (Heidelberg Engineering, Vista,
CA), and TOPCON3D OCT-1000 (Topcon Medical Systems,
Paramus, NJ) were the most reliable machines with excellent
results, especially in normal retinae. They noted that all the
SD-OCT systems used a raster line protocol, STRATUS (TD
OCT) (Carl Zeiss Meditec, Dublin, CA) used a radial line pro-
tocol, thus this potentially led to a higher number of artifacts
in pathologic conditions that directly affected the fovea. They
found that the error occurrence was not deeply dependent
on the noise quantity and they also inferred that the effective-
ness of the automated delimitation of retinal boundaries was
probably not dependent on the lateral resolution of the OCT
machine as well.
Giani et al.11 observed that in the epiretinal membrane
group, errors were more frequent in the non-central macula
and in delimiting the inner retinal boundary. In neovascular
and nonneovascular AMD groups, however, the errors affect-
ing the outer retinal boundary were more common. They also
reported that in the macular hole group, the most common
error was the imprecise recognition of hole shape, leading
to overestimation of retinal thickness in the outer layers adja-
cent to the hole center. In severe myopia, they noted that the
most common error was the translation of the retinal bound-
ary adjacent to the choroid. The authors explained that this
observation is occurring as a result of the significant reduc-
tion of retinal layer reflectivity and thickness typical of this
condition. The signal from the choroid was increased be-
cause of the reduced attenuation of the retina and this re-
sulted in shifting of the boundary positions by the software
toward the choroidal hyper reflectivity.
Han et al.10 reported that for both instruments, eyes with
uveitis had the highest percentage of scans with centration
errors. This result may be related to media opacity creating
a difficult view for the OCT operator to center the scan prop-
erly in uveitic eyes. They also observed that in eyes with
AMD, misidentifications of the outer retina were more com-
mon than misidentification of the inner retina for both CIR-
RUS (Carl Zeiss Meditec, Dublin, CA) and SPECTRALIS
(Heidelberg Engineering, Vista, CA). They inferred that this
is likely due to pathologic disruptions of the outer retina suchas drusen and choroidal neovascularization, which creates
challenges for proper appropriate outer segmentation line
placement. Kim et al.31 also reported a higher rate of
segmentation error in AMD, more in CIRRUS HD-OCT (Carl
Zeiss Meditec, Dublin, CA) compared to SPECTRALIS
(Heidelberg Engineering, Vista, CA) OCT.
To conclude, artifacts occur in all makes of OCT machines
and the first step to rectify these artifacts is by identifying
them.9 This can be done by looking at the topography
map, which would enable us to identify off-center artifacts.
Similarly, screening of individual scans helps us to identify im-
proper delineation of inner and outer retinal layers and out of
register artifacts. Looking at the rendered fundus image
helps us to note motion and blink artifacts. The next step
would be to take the appropriate remedial measures to
achieve more realistic information from this imaging tech-
nique. (Table 1) At the end, not all the artifacts are important
and affect the clinical management. The hope is that future
advancement in OCT technology would further reduce arti-
facts to improve the image quality and clinical management.Conflict of interest
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